As part of our commitment to accelerate pancreatic cancer research through the All Together We Can campaign, PanCAN announces ...

Dr. David DeNardo is a Professor of Medicine at Washington University, School of Medicine, in St. Louis (WUSM) and serves as Co-leader of Siteman Cancer Center’s Tumor Immunology Program, Leader of ...

Dr. An Ngo-Huang is an Associate Professor at The University of Texas MD Anderson Cancer Center, in the Department of Palliative, Rehabilitation, and Integrative Medicine. She is a board-certified ...

Dr. Boone is a tenured Associate Professor in the Department of Surgery and the Department of Microbiology, Immunology, and Cell Biology at West Virginia University and Chief of the Division of ...

Dr. Singhal is a physician-scientist and medical oncologist at Memorial Sloan Kettering Cancer Center. Her career goal is to establish an independent laboratory research program focused on ...

Dr. Christopher Kemp is a Professor in the Departments of Human Biology and Public Health Sciences at Fred Hutchinson (Fred Hutch) Cancer Center and a member of the Translational Data Science ...

Dr. Hosein is a board-certified Medical Oncologist specializing in gastrointestinal cancers and is a Professor of Medicine at the University of Miami Miller School of Medicine. He is also the ...

Dr. Kazuki N. Sugahara is a surgeon-scientist at the Pancreas Center and Herbert Irving Comprehensive Cancer Center at Columbia University, where he develops peptide-based strategies to improve cancer ...

Sita Kugel, PhD, is a Professor in the Human Biology Division and Leung Roy Family Endowed Chair. She serves as the Director of Basic and Translational Research in GI Oncology and the Deputy Director ...

Dr. John P. Morris IV is an Assistant Professor in the Department of Pharmacology at the University of North Carolina (UNC) Chapel Hill and a member of the UNC Lineberger Comprehensive Cancer Center.

The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...